ProBliva Psoriasis Shampoo-204
- Manufacturer
- CAVTECH HOLDING LLC
- Effective date
- 2026-07-10
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- daily-update
- Hydrated at
- 2026-07-29 05:10:13
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Salicylic Acid 3%
OTC - PURPOSE SECTION
Anti-Psoriasis, Anti-Seborrheic Dermatitis
DOSAGE & ADMINISTRATION SECTION
- COntrols the symptoms of Psoriasis.
- For the relief of the symptoms of itching, flaking & scaling associated with Psoriasis.
WARNINGS SECTION
- For external use only.
- psoriasis covers large areas of your body allergy or sensitivity to Sallicylic Acid.
OTC - WHEN USING SECTION
Avoid contact with the eye. If contact occurs, rinse eyes thoroughly with water.
OTC - STOP USE SECTION
conditon worsens or does not improve after regular use of this product as directed.
OTC - DO NOT USE SECTION
on children under 2 of age except under the advice and supervision of a doctor.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
if swallowed, get medical help or contact Poison Control Center right away.
INDICATIONS & USAGE SECTION
- Wet hair thoroughly
- Apply a liberal amount of shampoo and massage into lather
- Rinse hair well and repeat
- Allow lather to remain on scalp for several minutes
- For best results use at least twice a week or as directed by a doctor
OTHER SAFETY INFORMATION
- Store at room temperature (15-30°C/ 59-86°F)
- Protect from excessive heat and direct sunlight
INACTIVE INGREDIENT SECTION
Water, Sodium Laureth Sulfate, Cocamidopropyl Betaine, Ammonium Lauryl Sulfate, Cocamide Methyl MEA, Glycerin, PEG-120 Methyl Glucose Dioleate,Dimethicone, Sodium Chloride, Sodium Hydroxide,Sodium Lauroamphoacetate, Mentha Haplocalyx Oil,Silica Dimethicone Silylate, Dimethiconol,Phenoxyethanol, Sodium Benzoate, Cetyl Alcohol,Climbazole, Mentholum, Guar Hydroxypropyltrimoni-um Chloride, Piroctone Olamine, Trihydroxystearin,Bis-Aminopropyl Dimethicone, Betaine, Lauryl Lactate,Polyquaternium-10, Disodium EDTA, Melaleuca Alternifolia (Tea Tree) Leaf Oil, Rosmarinus Officinalis(Rosemary) Leaf Oil, Laureth-9, Polyquaternium-7,PEG-14M, Tea-Dodecylbenzenesulfonate,Acrylates/C10-30 Alkyl Acrylate Crosspolymer,Silica, BHT
OTC - QUESTIONS SECTION
service@problivabeauty.com
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
Product Linked Resources#
| Resource | Code type | Value | Equivalent identifiers | Source image |
|---|---|---|---|---|
| QR code link | QR Code | package.jpg |
Products#
Every source-derived product name is available through these pages.
- ProBliva Psoriasis Shampoo.
- Salicylic Acid 3%
- PHENOXYETHANOL
- COCAMIDOPROPYL BETAINE
- GUAR HYDROXYPROPYLTRIMONIUM CHLORIDE
- DIMETHICONOL (100000 CST)
- LAURYL LACTATE
- PEG-120 METHYL GLUCOSE DIOLEATE
- SILICA DIMETHYL SILYLATE
- SODIUM CHLORIDE
- TEA-DODECYLBENZENESULFONATE
- ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER (60000 MPA.S)
- MENTHA ARVENSIS LEAF OIL
- POLYQUATERNIUM-10 (1000 MPA.S AT 2%)
- POLYQUATERNIUM-7
- ROSMARINUS OFFICINALIS (ROSEMARY) LEAF OIL
- AMMONIUM LAURYL SULFATE
- SILICA
- SODIUM LAUROAMPHOACETATE
- PIROCTONE OLAMINE
- SODIUM BENZOATE
- SODIUM HYDROXIDE
- SODIUM LAURETH SULFATE
- CLIMBAZOLE
- TRIHYDROXYSTEARIN
- MAGNESIUM DISODIUM EDTA
- PEG-14M
- LEVOMENTHOL
- COCAMIDE METHYL MEA
- SALICYLIC ACID
- MELALEUCA ALTERNIFOLIA (TEA TREE) LEAF OIL
- WATER
- BETAINE
- LAURETH-9
- AMINOPROPYL DIMETHICONE (2000 MPA.S)
- GLYCERIN
- CETYL ALCOHOL
- DIMETHICONE
- BHT
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 85464-008 | 85464-008-01 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ProBliva Psoriasis Shampoo. | SALICYLIC ACID 3% | CAVTECH HOLDING LLC | 563e75f9-a1e2-2796-e063-6294a90aedb4 | 2026-07-10 | Warnings | 85464-008-01 85464-008 85464000801 563e75f9-a1e3-2796-e063-6294a90aedb4 563e75f9-a1e2-2796-e063-6294a90aedb4 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
